These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1469230)

  • 1. [Low grade malignant ovarian carcinomas. A retrospective study of 132 cases].
    Randrianjafisamindrakotroka NS; Hedelin G; Philippe E; Schaffer P
    J Gynecol Obstet Biol Reprod (Paris); 1992; 21(7):761-7. PubMed ID: 1469230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
    Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
    Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical factors and biomarkers in ovarian tumors development.
    Vrabie CD; Petrescu A; Waller M; Dina I
    Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ovarian carcinomas. Retrospective study of 318 cases].
    Randrianjafisamindrakotroka NS; Hedelin G; Philippe E; Schaffer P
    J Gynecol Obstet Biol Reprod (Paris); 1995; 24(7):711-6. PubMed ID: 8568178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian tumours: a study of 282 cases.
    Pilli GS; Suneeta KP; Dhaded AV; Yenni VV
    J Indian Med Assoc; 2002 Jul; 100(7):420, 423-4, 447. PubMed ID: 12674165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Borderline epithelial tumours of the ovary--a retrospective analysis of 31 cases.
    Kane SV; Bharadwaj R; Tongaonkar HB
    Indian J Cancer; 1999 Mar; 36(1):18-31. PubMed ID: 10810551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The malignant potential of adenofibroma and cystadenofibroma of the ovary and mesovarium. 118 cases including 13 proliferative and 5 carcinomatous].
    Randrianjafisamindrakotroka NS; Gasser B; Philippe E
    J Gynecol Obstet Biol Reprod (Paris); 1993; 22(1):33-8. PubMed ID: 8463564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants.
    Mayr D; Hirschmann A; Löhrs U; Diebold J
    Gynecol Oncol; 2006 Dec; 103(3):883-7. PubMed ID: 16806438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers.
    Chan JK; Teoh D; Hu JM; Shin JY; Osann K; Kapp DS
    Gynecol Oncol; 2008 Jun; 109(3):370-6. PubMed ID: 18395777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-grade ovarian serous carcinoma exhibits significantly higher p16 expression than low-grade serous carcinoma and serous borderline tumour.
    O'Neill CJ; McBride HA; Connolly LE; Deavers MT; Malpica A; McCluggage WG
    Histopathology; 2007 May; 50(6):773-9. PubMed ID: 17493241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface epithelial tumours of the ovary.
    Maheshwari V; Tyagi SP; Saxena K; Tyagi N; Sharma R; Aziz M; Hameed F
    Indian J Pathol Microbiol; 1994 Jan; 37(1):75-85. PubMed ID: 8088904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinoma of extrahepatic bile ducts and gallbladder metastatic to the ovary: a report of 16 cases.
    Khunamornpong S; Lerwill MF; Siriaunkgul S; Suprasert P; Pojchamarnwiputh S; Chiangmai WN; Young RH
    Int J Gynecol Pathol; 2008 Jul; 27(3):366-79. PubMed ID: 18580314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
    Veras E; Deavers MT; Silva EG; Malpica A
    Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preserving ovarian function in the treatment of epithelial and special (other) malignant ovarian tumors].
    Kolstad P
    Geburtshilfe Frauenheilkd; 1987 Oct; 47(10):683-9. PubMed ID: 2824278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum CA19.9 levels are commonly elevated in primary ovarian mucinous tumours but cannot be used to predict the histological subtype.
    Kelly PJ; Archbold P; Price JH; Cardwell C; McCluggage WG
    J Clin Pathol; 2010 Feb; 63(2):169-73. PubMed ID: 20154039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pattern of ovarian tumours among Malaysian women at General Hospital, Kuala Lumpur.
    Thanikasalam K; Ho CM; Adeed N; Shahidan MN; Azizah WK
    Med J Malaysia; 1992 Jun; 47(2):139-46. PubMed ID: 1337368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ovarian tumors of low malignant potential (borderline ovarian tumors)].
    Luchian AM; Pricop M
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):438-45. PubMed ID: 21870737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometrioid carcinoma simultaneously involving the uterus and the fallopian tube: a clinicopathologic study of 13 cases.
    Culton LK; Deavers MT; Silva EG; Liu J; Malpica A
    Am J Surg Pathol; 2006 Jul; 30(7):844-9. PubMed ID: 16819326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular carcinogenesis of ovarian carcinoma].
    Diebold J
    Verh Dtsch Ges Pathol; 2005; 89():77-83. PubMed ID: 18035676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.